MBD2 has been proven to significantly inhibit the expression of telomerase reverse transcriptase (TERT) via binding the hypermethylated region of the TERT promoter in liver, breast, cervical, and neuroblastoma cell lines.38 The gene discussed is MBD2; the disease is neuroblastoma.